The role of the pharmacist in cardiac risk reduction for patients with the metabolic syndrome
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: SAMU, Antal (Hung.Assoc.of Priv. Pharm, Budapest, Hungary)
- Co-author(s): Kiss, István (Semmelweis University, 2nd. Department of Internal Medicine, Budapest, Hungary)
Halmos, Gábor (Professor and Chair, Department of Biopharmacy, School of Pharmacy,, Debrecen, Hungary)
Recent epidemiologic studies have led to the discovery that MS is perhaps one of the most prevalent yet preventable diseases among adults in Hungary.
The aim of our study were to: provide information about healthy lifestyles and ways to prevent/postpone cardiometabolic diseases (CMD) increase awareness of the character of early The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.